Showing session: reset
Cancer Immunotherapy: Small Molecule Approaches
- Sort by:
- Browse by:
- Free
- slides video
- audio + slides
- All slides included
Targeting oncogeneic and host pathways to promote immunotherapy responsiveness
Thomas Frank Gajewski
University of Chicago, Chicago, IL, United States
- Free
- slides video
- audio + slides
- All slides included
Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity
Thomas W. Dubensky
Aduro Biotech, Inc., Berkeley, CA, United States
- Permission not
granted for presentation
IDO1 inhibition as a modifier of the immune composition of the tumor microenvironment and a component of combination immunotherapy for cancer
Peggy A. Scherle
Incyte Corporation, Wilmington, DE, United States